Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 6;11:4023–4040. doi: 10.2147/CMAR.S198886

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Ren et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-107 delivery into HLA-DR⁻CD33⁺MDSCs via TDEs secreted by gastric cancer cells.

Notes: HLA-DR⁻CD33⁺MDSCs were incubated with TDEs containing Cy3-labeled miR-107 for 6 hrs prior to examination for miR-107 internalization. Shown here are Wright stained image, magnification × 400, (A), CFSE proliferation dye, magnification × 100 (B, Cy3-miR-107 , magnification × 400 (C), and a merged image of CFSE and Cy3, magnification × 100 (D) showing internalization of miR-107 into proliferating HLA-DR⁻CD33⁺MDSCs. (E) HLA-DR⁻CD33⁺MDSCs were incubated with TDEs containing miR-107 for 24 hrs prior to collection for real-time quantitative PCR analysis. Shown here is relative expression of miR-107 and pre-miR-107 in the MDSCs. The data are presented as mean ± SD (n=6). **P<0.01.